Delivery Order SPE2DR25D9113-SPE2DR26FCHS8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award represents one...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through unrestricted competition. The delivery order...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vial format. This $1,113.42 firm fixed-price delivery order was issued on October 29, 2025, with an ultimate completion date of November 20, 2025, and carries no set-aside designation. The award leverages DMS Pharmaceutical Group's position as a regional prime...
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) in single-dose vials on October 20, 2025. The delivery order, with an ultimate completion date of November 10, 2025, carries no set-aside designation, allowing the woman-owned small business to compete directly against other qualified vendors. DMS Pharmaceutical Group, headquartered in Park Ridge, Illinois, is the sole awardee with no identified...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $36,196.84 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. This firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025, and carries no set-aside designation, indicating the award was made through...
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, represents a routine pharmaceutical supply requirement supporting Department of Defense medical operations. The award carries no...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in 1-dose vial formulations. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- SPE2DR25D9113Indefinite Delivery Contract
- SPE2DR25D9113-SPE2DR26FCHS8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries firm fixed-price terms and received no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award represents one of numerous delivery orders DMS Pharmaceutical Group has received from the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, and extending through December 31, 2036. The PPV-G GEN V contract, part of the broader $30.3 billion acquisition strategy, establishes DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products, biologics, and medical consumables to support Department of Defense healthcare operations worldwide. The company's established performance across diverse product categories and therapeutic areas positions it as a critical supplier within the federal pharmaceutical supply chain for military healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/10/25 |